Cortisone, whether used prophylactically or therapeutically, did not appear to have any beneficial effect in reducing the size of the mvocardial infarcts produced by coronary artery ligation in dogs. No significant differences were noted between the control and cortisone-treated animals in respect to the vascularity of the infarcted area or the rate of healing. J OHNSON, Scheinberg, Gerisch and Saltzstein reported recently that cortisone reduces the area of residual fibrosis resulting from experimental acute coronary occlusion.' Since the need for a method of reducing the size of myocardial infarcts is well recognized this report received much attention even prior to publication in this journal. Unfortunately, the result of similar experiments to be detailed here fail to confirm the claims made by Johnson and co-workers.
PROCEDURE
Two series of experiments were performed. In the first series 8 of 15 dogs were treated daily with 10 mg. per kilogram of cortisone acetate subcutaneously, starting six days prior to ligation of the left anterior ramus descendens coronary artery.
The remaining seven dogs were operated upon but received no cortisone treatment. The coronary arteries were ligated via a conservative intercostal approach by the two-stage technic of Harris2 at sites varying from 10 to 33 mm. from the point of origin of the artery. The cortisone injections were continued throughout the experiment, and each experiment terminated at the time indicated in table 1. Observations were made relative to the nature and amount of pleural and pericardial adhesions, the external appearance of the hearts, and the size of the infarcts as revealed by serial sectioning of the fresh specimens. Sections were taken for microscopic examination after suitable fixation in formalin.
After learning that our cortisone dosage was much higher than that used by the Detroit group' a second series of experiments was undertaken which followed their design except where more physiologic pro-From the Merck Institute for Therapeutic Research, Rahway, N. J. 544 cedures seemed desirable. Fourteen dogs were subjected to standardized ligation of the ramus descendens artery. The arteries were ligated by the two-stage technic at the point where the posterior margin of the left atrial appendage overlies the vessel. This corresponds roughly to the "high ligation" described by Johnson and associates.' Seven dogs received an intramuscular injection of 3 mg. per kilogram of cortisone acetate at the precise moment of complete occlusion of the artery and daily thereafter for the duration of the experiment. The remaining seven dogs were untreated. All dogs in this series received 200,000 units of penicillin daily for the first four postoperative days. Each experiment was terminated two weeks after coronary occlusion, the thorax carefully opened and the contents thoroughly examined before excision and fixation of the heart in formalin. After thorough fixation the site and completeness of ligation were verified on each heart before preparing 0.5 cm. serial sections. The outline of the infarct revealed on each section was traced on a glass slide, the trace transferred to tracing paper and the area of each trace determined by planimetry. The volume of each infarct was calculated by applying the formula for the calculation of the volume of a cylinder. Sections were then taken for microscopic examination.
RESULTS
First Series. Considerable variation was noted in the size of the infarcts in the control series (table 1). The size of the infarct did not correlate well with the site of occlusion. This observation confirms the experience of others.4 On comparing the size of the infarcts in the control series with the size of those in the cortisone series it is evident that by this method of measurement the infarcts are not smaller in the cortisone-treated hearts. As a matter of Circulation, Volume VIII, October, 1953 fact, the largest infarct (dog 14) occurred in a cortisone-treated animal, while the smallest (dog 3) occurred in a control animal.
Postoperative infections were more numerous in the cortisone series because antibiotics were not used prophylactically. However, the size of an infarct is determined within a few minutes after occluding the artery.5 Postoperative infections, therefore, could influence the rate of healing, but not the size of the infarct.
where between two and four weeks after the infarction (table 2) . Well-healed infarcts were seen as early as three weeks after the infarction. The only possibly significant difference between the control and cortisone-treated dogs might be the persistence of large necrotic areas in dog 13 (four weeks) and dog 15 (nine weeks), both cortisone treated. Both of these dogs had rather severe wound infections at the termination of the experiment. It may be noted that On microscopic examination, attention was given to the presence and extent of necrotic areas, the comparative concentrations of polymorphonuclear and mononuclear leukocytes, the number of fibroblasts and the extent to which fibrous tissue (scar) had been formed. The evaluation was done on a relative 0 to 4 plus basis. Necrotic tissue had essentially disappeared from the myocardium of untreated dogs some-control dog 5 (four weeks) also had some residual necrotic areas and a wound infection. On the other hand, it seems that infections do not necessarily delay the disappearance of necrotic areas since cortisone-treated dog 14 (seven weeks) had an active pericarditis, but his infarct was well healed and free of necrotic tissue. It cannot be said, therefore, that cortisone treatment directly delayed the disappearance of necrotic areas. It can be concluded, however, that cortisone treatment did not reduce the size of the infarcts or promote the healing process.
Second Series. This series differed from the previous series in many respects: the cortisone dose was reduced from 10 to 3 mg. per kilogram;
and, observations were made on the postoperative behavior and mortality.
No differences in postoperative activity or well-being were noted between the control and cortisone-treated dogs. All dogs exhibited their usual preoperative behavior. Our observations injection was intramuscular rather than subcutaneous; the first injection was made at the time of coronary occlusion rather than as pretreatment for a six day period; dogs were sacrificed two weeks after coronary occlusion; all dogs received antibiotics prophylactically;
do not coincide with those of Johnson and coworkers' who thought their cortisone-treated dogs were more active than the controls. A total of 16 dogs were operated upon. Two dogs died during the first 24 hour postoperative period. One of these was cortisone-treated and the other a control. No difference in mortality was observed, therefore. It should be pointed out, however, that the two-stage coronary ligation procedure was employed. This procedure was designed to reduce the mortality following acute coronary occlusion.2
Although surgical trauma was held to a minimum, some intrathoracic adhesions, usually visceral to parietal pleura, were observed in all dogs with one or two exceptions. No differences between the control and cortisonetreated dogs were observed. No intrathoracic infections were observed and only one minor wound infection occurred. Table 3 presents the calculated volume of the infarcts in the control and cortisone-treated (table 4) suggests such a relationship. If so, then, since the average infarct size in the cortisone-treated group is larger, more residual necrosis could be expected, but, since the difference in average infarct size is not significant, the apparent difference in residual necrosis is not significant either. experiments. Although the average volume of the cortisone series appears to be appreciably larger than the average control volume (8.95 cc. vs. 5.48 cc.), there is no statistically significant difference between them. These data certainly do not suggest that cortisone treatment reduces the size of the infarct. Since all observations were terminated two weeks postoperatively, the microscopic examination becomes particularly significant. In addition to the parameters examined in the previous experiment, an estimation was made of the degree of vascularity within the infarcted area. It is concluded that the second series, like the first, showed no effect of cortisone on the size of the infarct or its rate or mode of healing.
DIscUSSION
These results fail to confirm the claims made by Johnson, Scheinberg, Gerisch and Saltzstein.' No desirable effect of cortisone treatment on either the size of the infarct or its rate of healing was observed. Our results are similar to those reported by Chapman, Skaggs, Thomas and Green.6
Our postoperative mortality figures cannot be compared with those reported by Johnson and associates' because of the difference in the technic of coronary ligation. However, in view of the complete lack of confirmation of their main thesis and the fact that our studies do not indicate that cortisone increases the vascularity of the infarcted area, some question may be voiced concerning their mortality figures. Since, (a) acute mortality is due chiefly to ventricular fibrillation, (b) conditions leading to fibrillation are set up within one or two minutes after occlusion,7 and (c) ventricular fibrillation usually occurs within 20 to 30 minutes after occlusion,' it is difficult to imagine how a relatively small dose of highly insoluble cortisone (acetate) administered intramuscularly at the precise moment of coronary occlusion could protect the ventricle from fibrillation. It may be, however, that cortisone protects from fatal ventricular fibrillation by inhibiting production of, or by destroying some toxic substance from the ischemic area.8 SUMMARY The effect of cortisone acetate (3 to 10 mg. per kilogram) on the size and healing of myocardial infarcts was studied in two series of dogs. The size of the infarct in the hearts of cortisone-treated dogs did not differ significantly from the untreated controls, nor were any striking differences detected by microscopic examination of the infarcted areas. It is concluded that cortisone treatment does not reduce the size of infarcts resulting from acute coronary occlusion.
SUMARIo EsPANOL El uso de la cortisona profilacticamente o terapeuticamente no aparecio tener efecto beneficioso alguno en reducir el tamafio de infartos del miocardio producidos por medio de ligacion de la arteria coronaria en perros. No se noto diferencia significativa alguna entre los controles y los animales tratados con cortisona en cuanto respecta a la vascularidad y la cicatrizacion del infarto.
